Skip to main content

Aridhia, Glencoe Creating Software Tools for Personalized Medicine

NEW YORK (GenomeWeb News) – Aridhia Informatics and Glencoe Software today announced a partnership to develop products using real-world clinical, genetic, and research information in order to hasten the development of personalized therapies and improve patient outcomes.

The deal brings together Aridhia's capabilities in accessing, storing, and analyzing healthcare information and Glencoe's expertise in managing, sharing, and publishing large scientific datasets.

As part of the deal, Aridhia, based in Dundee, Scotland, will make a "major investment" in Seattle-based Glencoe. Financial details were not disclosed.

Both firms were founded based on technology developed at the University of Dundee. Formed in 2008, Aridhia is a health informatics joint venture between the university, NHS Tayside, and Sumerian and has received more than £6.5 million ($10.5 million) in investments in its history, it said.

Glencoe builds software tools for analyzing very large scientific image datasets.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.